Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine
Shifting from the historical TNM paradigm to the determination of molecular and genetic subtypes of tumors has been a major improvement to better picture cancerous diseases. The sharper the picture is, the better will be the possibility to develop subsequent strategies, thus achieving higher efficac...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2016-01-01
|
| Series: | Biomarker Insights |
| Online Access: | https://doi.org/10.4137/BMI.S33372 |